CLNN
Clene Inc.NASDAQCONSUMER DEFENSIVEPACKAGED FOODS
Key Statistics
Market Cap
$74.63M
P/E Ratio
—
EPS
$-3.25
Beta
0.92
52W High
$13.50
52W Low
$3.25
50-Day MA
$6.33
200-Day MA
$6.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | 134,000 |
| Gross Profit (TTM) | 111,000 |
| EBITDA | $-19.62M |
| Operating Margin | -13740.00% |
| Return on Equity | -1738.00% |
| Return on Assets | -56.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $-1.60 |
| Price-to-Book | 7.83 |
| Price-to-Sales (TTM) | 556.91 |
| EV/Revenue | 677.12 |
| EV/EBITDA | -1.13 |
| Quarterly Earnings Growth (YoY) | 61.40% |
| Quarterly Revenue Growth (YoY) | -81.50% |
| Shares Outstanding | $12.78M |
| Float | $10.50M |
| % Insiders | 17.06% |
| % Institutions | 20.44% |
Historical Volatility
HV 10-Day
66.27%
HV 20-Day
62.62%
HV 30-Day
124.30%
HV 60-Day
107.71%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($32.20 target)
1
Strong Buy5
BuyMore CONSUMER DEFENSIVE Stocks
Data last updated: 6/13/2026